Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05773768
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2023-02-15
Brief Title:
EHRA-PATHS Clinical and Health Economic Evaluation of New Care Pathways
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Study Overview
Official Title:
EHRA-PATHS Addressing Multimorbidity in Elderly Atrial Fibrillation Patients Through Interdisciplinary Patient-centred Systematic Care Pathways - Clinical and Health Economic Evaluation of New Care Pathways
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EHRA-PATHS
Brief Summary:
In elderly atrial fibrillation AF patients AF is usually a manifestation of risk factors and comorbidities not only limited to cardiovascular diseases Especially in elderly often more than two comorbidities are present The presence of comorbidities also affects outcomes in AF patients Current healthcare systems are single-disease focused which increases the risk of underdiagnosing replicating diagnostic tests and adverse drug-drug interactions placing a high burden on healthcare costs Healthcare systems and hospitals are in need of new care pathways to address the complexity of multimorbid AF patients and to reduce costs The EHRA-PATHS consortium set out to address this need for change in management for multimorbid elderly AF patients in Europe through the development of new care pathways The aim of this study is to evaluate the current management of risk factors and comorbidities and subsequently implement the newly developed care pathways and evaluate if these pathways lead to better management of risk factors and comorbidities in multimorbid elderly AF patients compared to current standard care
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None